These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3652924)

  • 1. Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain.
    Garbay-Jaureguiberry C; Esnault C; Delepierre M; Laugaa P; Laalami S; Le Pecq JB; Roques BP
    Drugs Exp Clin Res; 1987; 13(6):353-7. PubMed ID: 3652924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
    Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
    Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses.
    Pothier J; Delepierre M; Barsi MC; Garbay-Jaureguiberry C; Igolen J; Le Bret M; Roques BP
    Biopolymers; 1991 Oct; 31(11):1309-23. PubMed ID: 1777582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series.
    Garbay-Jaureguiberry C; Laugâa P; Delepierre M; Laalami S; Muzard G; Le Pecq JB; Roques BP
    Anticancer Drug Des; 1987 Apr; 1(4):323-35. PubMed ID: 3450302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.
    Delepierre M; Maroun R; Garbay-Jaureguiberry C; Igolen J; Roques BP
    J Mol Biol; 1989 Nov; 210(1):211-28. PubMed ID: 2585517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetrical bisintercalators as potential antitumor agents.
    Léon P; Garbay-Jaureguiberry C; Lambert B; Le Pecq JB; Roques BP
    J Med Chem; 1988 May; 31(5):1021-6. PubMed ID: 3283364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
    Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
    Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
    Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
    J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor series.
    Garbay-Jaureguiberry C; Barsi MC; Jacquemin-Sablon A; Le Pecq JB; Roques BP
    J Med Chem; 1992 Jan; 35(1):72-81. PubMed ID: 1732535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes.
    Pindur U; Marotto A; Schulze E; Fischer G
    Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis-pyridoquinolines as new bifunctional intercalators for DNA.
    Malesani G; Chiarelotto G; Ferlin MG; Bordin F; Baccichetti F; Carlassare F; Vedaldi D; Dall'Acqua F
    Farmaco Sci; 1984 Nov; 39(11):925-34. PubMed ID: 6519263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the antitumor activity by methyl substitutions in the series of 7H-pyridocarbazole monomers and dimers.
    Léon P; Garbay-Jaureguiberry C; Barsi MC; Le Pecq JB; Roques BP
    J Med Chem; 1987 Nov; 30(11):2074-80. PubMed ID: 3669015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
    Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
    Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
    Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
    Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
    Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumoral activity of trisubstituted dihydrobenzo(a)carbazoles. Part III.
    Segall A; Pizzorno MT
    Pharmazie; 2000 Oct; 55(10):766-7. PubMed ID: 11082840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
    Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
    J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
    Phillips DR; Baguley BC; Brownlee RT; Cacioli P; Chandler CJ; Kyratzis I; Reiss JA; Scourides PA
    Drug Des Deliv; 1990 Mar; 5(3):203-19. PubMed ID: 1670502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parameters.
    Markovits J; Garbay-Jaureguiberry C; Roques BP; Le Pecq JB
    Eur J Biochem; 1989 Mar; 180(2):359-66. PubMed ID: 2924770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.